Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats

被引:0
|
作者
Shizuka Aritomi
Kazumi Niinuma
Tetsuya Ogawa
Tomoyuki Konda
Kosaku Nitta
机构
[1] Ajinomoto Pharmaceuticals Co.,Research Center
[2] Ltd.,Department of Medicine, Kidney Center
[3] Tokyo Women’s Medical University,Department of Medicine, Medical Center East
[4] Tokyo Women’s Medical University,undefined
来源
关键词
Cilnidipine; Streptozotocin; Blood pressure; Proteinuria; Renoprotection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:41 / 50
页数:9
相关论文
共 50 条
  • [41] Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats
    Matsuyama, Narihisa
    Tsutsumi, Takeshi
    Kubota, Nami
    Nakajima, Toshiaki
    Suzuki, Hiroshi
    Takeyama, Youici
    HYPERTENSION RESEARCH, 2009, 32 (08) : 721 - 726
  • [42] Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy
    Schiffrin, EL
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02): : 173 - 175
  • [43] Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats
    Narihisa Matsuyama
    Takeshi Tsutsumi
    Nami Kubota
    Toshiaki Nakajima
    Hiroshi Suzuki
    Youici Takeyama
    Hypertension Research, 2009, 32 : 721 - 726
  • [44] Effects of Angiotensin II Type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats
    Takemori, Kumiko
    Inoue, Takao
    Ito, Hiroyuki
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [45] Effects of Angiotensin II Type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats
    Kumiko Takemori
    Takao Inoue
    Hiroyuki Ito
    Lipids in Health and Disease, 12
  • [46] The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats
    Kamper, Maria
    Tsimpoukidi, Olia
    Chatzigeorgiou, Antonios
    Lymberi, Maria
    Kamper, Elli F.
    TRANSLATIONAL RESEARCH, 2010, 156 (01) : 26 - 36
  • [47] Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE-inhibitor in diabetic nephropathy.
    Rossing, K
    Jacobsen, PK
    Pietraszek, L
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 601A - 601A
  • [48] Effects of endothelin receptor antagonists on the progression of diabetic nephropathy
    Hocher, B
    Schwarz, A
    Reinbacher, D
    Jacobi, J
    Lun, A
    Priem, F
    Bauer, C
    Neumayer, HH
    Raschack, M
    NEPHRON, 2001, 87 (02): : 161 - 169
  • [49] Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
    Sun, Li-Jing
    Sun, Yan-Ni
    Shan, Jian-Ping
    Jiang, Geng-Ru
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 609 - 618
  • [50] Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats
    Ikeda, Fuki
    Azuma, Kosuke
    Ogihara, Takeshi
    Toyofuku, Yukiko
    Otsuka, Ajko
    Mita, Tomoya
    Hirose, Takahisa
    Tanaka, Yasushi
    Kawamori, Ryuzo
    Watada, Hirotaka
    ENDOCRINE JOURNAL, 2007, 54 (04) : 605 - 612